Rural and Remote Health Journal photo
African section Asian section European section International section Latin American section North American section
current articles
information for authors
status/user profile
about us

Short Communication

Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care

Submitted: 3 October 2013
Revised: 30 April 2014
Accepted: 16 May 2014
Published: 30 October 2014

Full text: You can view the full article, or view a printable version.
Comments: (login to access the comments on this article)

Author(s) : Spaeth BA, Shephard MDS, Schatz S.

Mark Shephard

Citation: Spaeth BA, Shephard MDS, Schatz S.  Point-of-care testing for haemoglobin A1c in remote Australian Indigenous communities improves timeliness of diabetes care. Rural and Remote Health (Internet) 2014; 14: 2849. Available: (Accessed 18 October 2017)


Introduction:  In remote Australia timely access to pathology results and subsequent follow-up of patients for treatment is very challenging due to the long distances to the nearest laboratory. Point-of-care testing (POCT) offers a practical solution for pathology service provision in such remote communities. Since 2008, POCT for haemoglobin A1c (HbA1c) has been conducted in remote Northern Territory (NT) health centres for diabetes management of Indigenous patients through the national Quality Assurance in Aboriginal and Torres Strait Island Medical Services (QAAMS) Program.
Methods:  Point-of-care testing HbA1c results performed on Indigenous diabetes patients in the NT from July 2008 to April 2011 was accessed via the NT’s electronic patient information system. Patients who had three or more HbA1c results performed by POCT across this period were assessed to determine their overall change in glycaemic control. An audit of 40 of these Indigenous diabetes patients (who exhibited a decrease in HbA1c levels of more than 1.5%) was undertaken to compare clinical and operational efficiency of POCT versus laboratory testing over an equivalent time period (15 months).
Results:  No change in glycaemic control was observed when these patients received laboratory HbA1c testing prior to the introduction of POCT. Long turnaround times for receipt of results and follow-up consultation with patients were identified during this period, compared to immediate receipt and actioning of results using POCT. Frequency of HbA1c testing was higher with POCT than for the laboratory.
Conclusions:  This audit demonstrates that POCT can significantly improve the timeliness and clinical follow-up of pathology results in remote locations, while also reinforcing the clinical and cultural effectiveness of POCT and its critical role in assisting to improve diabetes management in Indigenous Australians.

Key words: Australia, diabetes, haemoglobin A1c, Indigenous, point-of-care testing, QAAMS, timeliness.

This abstract has been viewed 3005 times since 30-Oct-2014.